483 filings
Page 16 of 25
POS AM
h2fghaul
9 Apr 10
Prospectus update (post-effective amendment)
12:00am
ARS
muiqvs vx3b2rd4
6 Apr 10
Annual report to shareholders
12:00am
DEFA14A
rl0xqxsgvpr2ecoo6 y1
6 Apr 10
Additional proxy soliciting materials
12:00am
CT ORDER
5c8kozltefrssjdct9n
2 Apr 10
Confidential treatment order
12:00am
8-K
fvf4l8q9dpnz7x bc
11 Mar 10
Departure of Directors or Certain Officers
12:00am
424B3
ww2tk
10 Mar 10
Prospectus supplement
12:00am
POS AM
ezo9ytk4g8hj4jlb
10 Mar 10
Prospectus update (post-effective amendment)
12:00am
POS AM
6bqz6esw92m
10 Mar 10
Prospectus update (post-effective amendment)
12:00am
424B3
arm734l6by0 12p
10 Mar 10
Prospectus supplement
12:00am
8-K
suespkxz
8 Mar 10
Alexza Reports 2009 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
12:00am
424B3
dbq7 espwj
17 Feb 10
Prospectus supplement
12:00am
424B3
fcrnib
17 Feb 10
Prospectus supplement
12:00am
8-K
4jvkg yqh2qxv
16 Feb 10
Departure of Directors or Certain Officers
12:00am
424B3
p0fe3h 32llto
12 Feb 10
Prospectus supplement
12:00am
424B3
mizpjui18j y7lomjm
12 Feb 10
Prospectus supplement
12:00am
8-K
o6k6fd0ad4 4ubf79mr
11 Feb 10
Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato® Loxapine) in North America
12:00am
8-K
akjt2od uk
11 Feb 10
Other Events
12:00am
S-8
2bmn0fyuhtqc4c7j
10 Feb 10
Registration of securities for employees
12:00am